The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Oral Mucositis-Global Market Insights and Sales Trends 2024
Synopsis
Mucositis occurs when cancer treatments break down the rapidly divided epithelial cells lining the gastro-intestinal tract (which goes from the mouth to the anus), leaving the mucosal tissue open to ulceration and infection. Mucosal tissue, also known as mucosa or the mucous membrane, lines all body passages that communicate with the air, such as the respiratory and alimentary tracts, and have cells and associated glands that secrete mucus. The part of this lining that covers the mouth, called the oral mucosa, is one of the most sensitive parts of the body and is particularly vulnerable to chemotherapy and radiation. The oral cavity is the most common location for mucositis.
The global Oral Mucositis market size is expected to reach US$ 1930.4 million by 2029, growing at a CAGR of 4.0% from 2023 to 2029. The market is mainly driven by the significant applications of Oral Mucositis in various end use industries. The expanding demands from the Hospitals, Specialty Clinics and Others,, are propelling Oral Mucositis market. Mouthwash, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Pain Control Medication segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oral Mucositis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oral Mucositis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oral Mucositis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oral Mucositis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oral Mucositis covered in this report include GSK, Pfizer, Colgate-Palmolive, Norgine, Sobi, Bausch Health, EUSA Pharma, Camurus and Innovation Pharmaceuticals, etc.
The global Oral Mucositis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Pfizer
Colgate-Palmolive
Norgine
Sobi
Bausch Health
EUSA Pharma
Camurus
Innovation Pharmaceuticals
Clinigen Group
Helsinn Healthcare
Alliance Pharma
Amag Pharmaceuticals
Oragenics
Soligenix
Himalaya
Global Oral Mucositis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Mucositis market, Segment by Type:
Mouthwash
Pain Control Medication
Other
Global Oral Mucositis market, by Application
Hospitals
Specialty Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Oral Mucositis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Mucositis occurs when cancer treatments break down the rapidly divided epithelial cells lining the gastro-intestinal tract (which goes from the mouth to the anus), leaving the mucosal tissue open to ulceration and infection. Mucosal tissue, also known as mucosa or the mucous membrane, lines all body passages that communicate with the air, such as the respiratory and alimentary tracts, and have cells and associated glands that secrete mucus. The part of this lining that covers the mouth, called the oral mucosa, is one of the most sensitive parts of the body and is particularly vulnerable to chemotherapy and radiation. The oral cavity is the most common location for mucositis.
The global Oral Mucositis market size is expected to reach US$ 1930.4 million by 2029, growing at a CAGR of 4.0% from 2023 to 2029. The market is mainly driven by the significant applications of Oral Mucositis in various end use industries. The expanding demands from the Hospitals, Specialty Clinics and Others,, are propelling Oral Mucositis market. Mouthwash, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Pain Control Medication segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oral Mucositis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oral Mucositis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oral Mucositis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oral Mucositis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oral Mucositis covered in this report include GSK, Pfizer, Colgate-Palmolive, Norgine, Sobi, Bausch Health, EUSA Pharma, Camurus and Innovation Pharmaceuticals, etc.
The global Oral Mucositis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Pfizer
Colgate-Palmolive
Norgine
Sobi
Bausch Health
EUSA Pharma
Camurus
Innovation Pharmaceuticals
Clinigen Group
Helsinn Healthcare
Alliance Pharma
Amag Pharmaceuticals
Oragenics
Soligenix
Himalaya
Global Oral Mucositis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Mucositis market, Segment by Type:
Mouthwash
Pain Control Medication
Other
Global Oral Mucositis market, by Application
Hospitals
Specialty Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Oral Mucositis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Oral Mucositis
1.1 Oral Mucositis Market Overview
1.1.1 Oral Mucositis Product Scope
1.1.2 Oral Mucositis Market Status and Outlook
1.2 Global Oral Mucositis Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Oral Mucositis Market Size by Region (2018-2029)
1.4 Global Oral Mucositis Historic Market Size by Region (2018-2023)
1.5 Global Oral Mucositis Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Oral Mucositis Market Size (2018-2029)
1.6.1 North America Oral Mucositis Market Size (2018-2029)
1.6.2 Europe Oral Mucositis Market Size (2018-2029)
1.6.3 Asia-Pacific Oral Mucositis Market Size (2018-2029)
1.6.4 Latin America Oral Mucositis Market Size (2018-2029)
1.6.5 Middle East & Africa Oral Mucositis Market Size (2018-2029)
2 Oral Mucositis Market by Type
2.1 Introduction
2.1.1 Mouthwash
2.1.2 Pain Control Medication
2.1.3 Other
2.2 Global Oral Mucositis Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Oral Mucositis Historic Market Size by Type (2018-2023)
2.2.2 Global Oral Mucositis Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Oral Mucositis Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Oral Mucositis Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Oral Mucositis Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Oral Mucositis Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Oral Mucositis Revenue Breakdown by Type (2018-2029)
3 Oral Mucositis Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Specialty Clinics
3.1.3 Others
3.2 Global Oral Mucositis Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Oral Mucositis Historic Market Size by Application (2018-2023)
3.2.2 Global Oral Mucositis Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Oral Mucositis Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Oral Mucositis Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Oral Mucositis Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Oral Mucositis Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Oral Mucositis Revenue Breakdown by Application (2018-2029)
4 Oral Mucositis Competition Analysis by Players
4.1 Global Oral Mucositis Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Mucositis as of 2022)
4.3 Date of Key Players Enter into Oral Mucositis Market
4.4 Global Top Players Oral Mucositis Headquarters and Area Served
4.5 Key Players Oral Mucositis Product Solution and Service
4.6 Competitive Status
4.6.1 Oral Mucositis Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GSK
5.1.1 GSK Profile
5.1.2 GSK Main Business
5.1.3 GSK Oral Mucositis Products, Services and Solutions
5.1.4 GSK Oral Mucositis Revenue (US$ Million) & (2018-2023)
5.1.5 GSK Recent Developments
5.2 Pfizer
5.2.1 Pfizer Profile
5.2.2 Pfizer Main Business
5.2.3 Pfizer Oral Mucositis Products, Services and Solutions
5.2.4 Pfizer Oral Mucositis Revenue (US$ Million) & (2018-2023)
5.2.5 Pfizer Recent Developments
5.3 Colgate-Palmolive
5.3.1 Colgate-Palmolive Profile
5.3.2 Colgate-Palmolive Main Business
5.3.3 Colgate-Palmolive Oral Mucositis Products, Services and Solutions
5.3.4 Colgate-Palmolive Oral Mucositis Revenue (US$ Million) & (2018-2023)
5.3.5 Norgine Recent Developments
5.4 Norgine
5.4.1 Norgine Profile
5.4.2 Norgine Main Business
5.4.3 Norgine Oral Mucositis Products, Services and Solutions
5.4.4 Norgine Oral Mucositis Revenue (US$ Million) & (2018-2023)
5.4.5 Norgine Recent Developments
5.5 Sobi
5.5.1 Sobi Profile
5.5.2 Sobi Main Business
5.5.3 Sobi Oral Mucositis Products, Services and Solutions
5.5.4 Sobi Oral Mucositis Revenue (US$ Million) & (2018-2023)
5.5.5 Sobi Recent Developments
5.6 Bausch Health
5.6.1 Bausch Health Profile
5.6.2 Bausch Health Main Business
5.6.3 Bausch Health Oral Mucositis Products, Services and Solutions
5.6.4 Bausch Health Oral Mucositis Revenue (US$ Million) & (2018-2023)
5.6.5 Bausch Health Recent Developments
5.7 EUSA Pharma
5.7.1 EUSA Pharma Profile
5.7.2 EUSA Pharma Main Business
5.7.3 EUSA Pharma Oral Mucositis Products, Services and Solutions
5.7.4 EUSA Pharma Oral Mucositis Revenue (US$ Million) & (2018-2023)
5.7.5 EUSA Pharma Recent Developments
5.8 Camurus
5.8.1 Camurus Profile
5.8.2 Camurus Main Business
5.8.3 Camurus Oral Mucositis Products, Services and Solutions
5.8.4 Camurus Oral Mucositis Revenue (US$ Million) & (2018-2023)
5.8.5 Camurus Recent Developments
5.9 Innovation Pharmaceuticals
5.9.1 Innovation Pharmaceuticals Profile
5.9.2 Innovation Pharmaceuticals Main Business
5.9.3 Innovation Pharmaceuticals Oral Mucositis Products, Services and Solutions
5.9.4 Innovation Pharmaceuticals Oral Mucositis Revenue (US$ Million) & (2018-2023)
5.9.5 Innovation Pharmaceuticals Recent Developments
5.10 Clinigen Group
5.10.1 Clinigen Group Profile
5.10.2 Clinigen Group Main Business
5.10.3 Clinigen Group Oral Mucositis Products, Services and Solutions
5.10.4 Clinigen Group Oral Mucositis Revenue (US$ Million) & (2018-2023)
5.10.5 Clinigen Group Recent Developments
5.11 Helsinn Healthcare
5.11.1 Helsinn Healthcare Profile
5.11.2 Helsinn Healthcare Main Business
5.11.3 Helsinn Healthcare Oral Mucositis Products, Services and Solutions
5.11.4 Helsinn Healthcare Oral Mucositis Revenue (US$ Million) & (2018-2023)
5.11.5 Helsinn Healthcare Recent Developments
5.12 Alliance Pharma
5.12.1 Alliance Pharma Profile
5.12.2 Alliance Pharma Main Business
5.12.3 Alliance Pharma Oral Mucositis Products, Services and Solutions
5.12.4 Alliance Pharma Oral Mucositis Revenue (US$ Million) & (2018-2023)
5.12.5 Alliance Pharma Recent Developments
5.13 Amag Pharmaceuticals
5.13.1 Amag Pharmaceuticals Profile
5.13.2 Amag Pharmaceuticals Main Business
5.13.3 Amag Pharmaceuticals Oral Mucositis Products, Services and Solutions
5.13.4 Amag Pharmaceuticals Oral Mucositis Revenue (US$ Million) & (2018-2023)
5.13.5 Amag Pharmaceuticals Recent Developments
5.14 Oragenics
5.14.1 Oragenics Profile
5.14.2 Oragenics Main Business
5.14.3 Oragenics Oral Mucositis Products, Services and Solutions
5.14.4 Oragenics Oral Mucositis Revenue (US$ Million) & (2018-2023)
5.14.5 Oragenics Recent Developments
5.15 Soligenix
5.15.1 Soligenix Profile
5.15.2 Soligenix Main Business
5.15.3 Soligenix Oral Mucositis Products, Services and Solutions
5.15.4 Soligenix Oral Mucositis Revenue (US$ Million) & (2018-2023)
5.15.5 Soligenix Recent Developments
5.16 Himalaya
5.16.1 Himalaya Profile
5.16.2 Himalaya Main Business
5.16.3 Himalaya Oral Mucositis Products, Services and Solutions
5.16.4 Himalaya Oral Mucositis Revenue (US$ Million) & (2018-2023)
5.16.5 Himalaya Recent Developments
6 North America
6.1 North America Oral Mucositis Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Oral Mucositis Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Oral Mucositis Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Oral Mucositis Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Oral Mucositis Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Oral Mucositis Market Dynamics
11.1 Oral Mucositis Industry Trends
11.2 Oral Mucositis Market Drivers
11.3 Oral Mucositis Market Challenges
11.4 Oral Mucositis Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
